Provided by Tiger Fintech (Singapore) Pte. Ltd.

Solana

7.76
-2.3500-23.24%
Post-market: 8.220.4600+5.93%19:58 EDT
Volume:1.61M
Turnover:15.63M
Market Cap:312.69M
PE:0.00
High:12.18
Open:10.33
Low:7.40
Close:10.11
52wk High:1,200.00
52wk Low:5.37
Shares:40.30M
Float Shares:36.98M
Volume Ratio:1.32
T/O Rate:4.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3,249.8933
EPS(LYR):-3,249.8932
ROE:-344.28%
ROA:-108.35%
PB:51.89
PE(LYR):0.00

Loading ...

Company Profile

Company Name:
Solana
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
21
Office Location:
642 Newtown Yardley Road,Suite 100,Newtown,Pennsylvania,United States
Zip Code:
18940
Fax:
- -
Introduction:
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

Directors

Name
Position
Dane C. Andreeff
President and Chief Executive Officer, Director
Joseph Chee
Executive Chairman and Director
Cosmo Jiang
Director

Shareholders

Name
Position
Dane C. Andreeff
President and Chief Executive Officer, Director
Jeffrey S. Mathiesen
Chief Financial Officer, Treasurer and Secretary
Antonella Favit Van Pelt
Chief Medical Officer